Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease

BACKGROUND: Purified intravenous immunoglobulin (IVIG) obtained from the plasma of healthy humans is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. IVIG contains naturally occurring auto-antibodies, including antibodies (Abs) against β-...

Descripción completa

Detalles Bibliográficos
Autores principales: Magga, Johanna, Puli, Lakshman, Pihlaja, Rea, Kanninen, Katja, Neulamaa, Suvi, Malm, Tarja, Härtig, Wolfgang, Grosche, Jens, Goldsteins, Gundars, Tanila, Heikki, Koistinaho, Jari, Koistinaho, Milla
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004875/
https://www.ncbi.nlm.nih.gov/pubmed/21138577
http://dx.doi.org/10.1186/1742-2094-7-90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004875/
https://www.ncbi.nlm.nih.gov/pubmed/21138577
http://dx.doi.org/10.1186/1742-2094-7-90

Ejemplares similares